Patents by Inventor Duojia Pan
Duojia Pan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11491139Abstract: Yes-associated protein (Yap), a downstream co-activator of the Hippo pathway, is highly expressed in the Treg cell subset, and is critical to maintain its suppressive activity. Originally discovered in Drosophila melanogaster, the Hippo signaling pathway is a major regulator of cellular growth and proliferation in mammals. Loss of Yap expression in Treg cells can lead to superior anti-tumor immune responses, and thus, Yap is an important immunotherapeutic target for cancer.Type: GrantFiled: February 12, 2016Date of Patent: November 8, 2022Assignee: The Johns Hopkins UniversityInventors: Fan Pan, Duojia Pan, Drew M. Pardoll, Joseph Barbi, Benjamin Park
-
Publication number: 20220112279Abstract: The present invention relates to compositions and methods for treating cancer by targeting the Activin signaling pathway. In certain embodiments, combining Activin blockade with immunomodulation alters regulatory T (Treg) cell-mediated immune regulation and treats cancer.Type: ApplicationFiled: December 23, 2021Publication date: April 14, 2022Inventors: Fan Pan, Duojia Pan, Drew M. Pardoll, Joseph Barbi, Juan Fu
-
Patent number: 11236156Abstract: The present invention relates to compositions and methods for treating cancer by targeting the Activin signaling pathway. In certain embodiments, combining Activin blockade with immunomodulation alters regulatory T (Treg) cell-mediated immune regulation and treats cancer.Type: GrantFiled: February 10, 2017Date of Patent: February 1, 2022Assignee: The Johns Hopkins UniversityInventors: Fan Pan, Duojia Pan, Drew M. Pardoll, Joseph Barbi, Juan Fu
-
Publication number: 20190077855Abstract: The present invention relates to compositions and methods for treating cancer by targeting the Activin signaling pathway. In certain embodiments, combining Activin blockade with immunomodulation alters regulatory T (Treg) cell-mediated immune regulation and treats cancer.Type: ApplicationFiled: February 10, 2017Publication date: March 14, 2019Applicant: The Johns Hopkins UniversityInventors: Fan Pan, Duojia Pan, Drew M. Pardoll, Joseph Barbi, Juan Fu
-
Publication number: 20190046583Abstract: The present invention relates to novel compositions and methods to produce 3D organ equivalents of the brain (i.e. “mini-brains”). The invention also relates to methods of using human induced pluripotent stem cells, a combination of growth and other soluble factors and gyratory shaking. Cells from healthy or diseased donors or animals can be used to allow testing different genetic backgrounds. The model can be further enhanced by using genetically modified cells, adding micro-glia or their precursors or indicator cells (e.g. with reporter genes or tracers) as well as adding endothelial cells to form a blood-brain-barrier.Type: ApplicationFiled: February 10, 2017Publication date: February 14, 2019Applicant: Johns Hopkins Technology VenturesInventors: Fan Pan, Duojia Pan, Drew M. Pardoll, Joseph Barbi, Juan Fu
-
Publication number: 20180021306Abstract: Yes-associated protein (Yap), a downstream co-activator of the Hippo pathway, is highly expressed in the Treg cell subset, and is critical to maintain its suppressive activity. Originally discovered in Drosophila melanogaster, the Hippo signaling pathway is a major regulator of cellular growth and proliferation in mammals. Loss of Yap expression in Treg cells can lead to superior anti-tumor immune responses, and thus, Yap is an important immunotherapeutic target for cancer.Type: ApplicationFiled: February 12, 2016Publication date: January 25, 2018Inventors: Fan PAN, Duojia PAN, Drew M. PARDOLL, Joseph BARBI, Benjamin PARK
-
Patent number: 7556942Abstract: Tumor suppressor genes (TSGs) play a major role in the pathogenesis of human cancers. Here, a new TSG designated hippo (hpo) is described, and the human homolog mst2 is identified as an additional TSG. hpo as a gene that regulates both cell proliferation and cell death in Drosophila, and encodes a Ste-20 family protein kinase that binds to and phosphorylates the tumor suppressor protein Salvador (Sav), which is known to interact with the Warts (Wts) protein kinase. Loss of hpo results in elevated transcription of the cell cycle regulator cyclin E and the cell-death inhibitor diap1, leading to increased proliferation and reduced apoptosis. Further, hpo, sav, and wts define a pathway that regulates diap1 at the transcriptional level. A human homolog of hpo completely rescues the overgrowth phenotype of Drosophila hpo? mutants.Type: GrantFiled: July 15, 2004Date of Patent: July 7, 2009Assignee: Board of Regents, The University of Texas SystemInventor: Duojia Pan
-
Patent number: 7537759Abstract: The invention provides methods and compositions relating to Kuz involvement in angiogenesis.Type: GrantFiled: March 21, 2005Date of Patent: May 26, 2009Assignee: The Regents of the University of CaliforniaInventors: Duojia Pan, Gerald M. Rubin, Hongbing Zhang
-
Publication number: 20050171024Abstract: The invention provides methods and compositions relating to Kuz involvement in angiogenesis.Type: ApplicationFiled: March 21, 2005Publication date: August 4, 2005Inventors: Duojia Pan, Gerald Rubin, Hongbing Zhang
-
Patent number: 6872750Abstract: The invention provides methods and compositions relating to Kuz involvement in angiogenesis.Type: GrantFiled: February 6, 2002Date of Patent: March 29, 2005Assignee: Regents of the University of CaliforniaInventors: Duojia Pan, Gerald M. Rubin, Hongbing Zhang
-
Publication number: 20050053592Abstract: Tumor suppressor genes (TSGs) play a major role in the pathogenesis of human cancers. Here, a new TSG designated hippo (hpo) is described, and the human homolog mst2 is identified as an additional TSG. hpo as a gene that regulates both cell proliferation and cell death in Drosophila, and encodes a Ste-20 family protein kinase that binds to and phosphorylates the tumor suppressor protein Salvador (Sav), which is known to interact with the Warts (Wts) protein kinase. Loss of hpo results in elevated transcription of the cell cycle regulator cyclin E and the cell-death inhibitor diap1, leading to increased proliferation and reduced apoptosis. Further, hpo, sav, and wts define a pathway that regulates diap1 at the transcriptional level. A human homolog of hpo completely rescues the overgrowth phenotype of Drosophila hpo? mutants.Type: ApplicationFiled: July 15, 2004Publication date: March 10, 2005Inventor: Duojia Pan
-
Publication number: 20020132778Abstract: The invention provides methods and compositions relating to Kuz involvement in angiogenesis.Type: ApplicationFiled: February 6, 2002Publication date: September 19, 2002Applicant: The Regents of the University of CaliforniaInventors: Duojia Pan, Gerald M. Rubin, Hongbing Zhang
-
Publication number: 20020127621Abstract: Members of a novel family of polypeptides, the KUZ family, are metalloproteases involved in neuronal partitioning and neuronal development. The invention provides KUZ poylpeptides, antibodies that bind the KUZ polypeptides, KUZ encoding nucleic acids, methods for identifying cells expressing the KUZ polypeptides, methods of identifying ligands that bind to the subject proteins and methods of blocking KUZ polypeptide/ligand interactions.Type: ApplicationFiled: May 31, 2001Publication date: September 12, 2002Inventors: Gerald M. Rubin, Duojia Pan, Jenny Rooke, Reza Yavari, Tian Xu
-
Patent number: 6436629Abstract: The invention provides methods and compositions relating to Kuz involvement in angiogenesis.Type: GrantFiled: October 27, 2000Date of Patent: August 20, 2002Assignee: The Regents of the University of CaliforniaInventors: Duojia Pan, Gerald M. Rubin, Hongbing Zhang
-
Patent number: 6399350Abstract: Members of a novel family of polypeptides, the KUZ family, are metalloproteases involved in neuronal partitioning and neuronal development. The invention provides KUZ poylpeptides, antibodies that bind the KUZ polypeptides, KUZ encoding nucleic acids, methods for identifying cells expressing the KUZ polypeptides, methods of identifying ligands that bind to the subject proteins and methods of blocking KUZ polypeptide/ligand interactions.Type: GrantFiled: May 31, 2001Date of Patent: June 4, 2002Assignee: The Regents of the University of CaliforniaInventors: Gerald M. Rubin, Duojia Pan, Jenny Rooke, Reza Yavari, Tian Xu
-
Patent number: 6319704Abstract: Members of a novel family of polypeptides, the KUZ family, are metalloproteases involved in neuronal partitioning and neuronal development.Type: GrantFiled: November 8, 2000Date of Patent: November 20, 2001Assignees: The Regents of the University of California, Yale UniversityInventors: Gerald M. Rubin, Duojia Pan, Jenny Rooke, Reza Yavari, Tian Xu
-
Patent number: 6190876Abstract: Members of a novel family of polypeptides, the KUZ family, are metalloproteases involved in neuronal partitioning and neuronal development. The invention provides KUZ poylpeptides, antibodies that bind the KUZ polypeptides, KUZ encoding nucleic acids, methods for identifying cells expressing the KUZ polypeptides, methods of identifying ligands that bind to the subject proteins and methods of blocking KUZ polypeptide/ligand interactions.Type: GrantFiled: April 2, 1999Date of Patent: February 20, 2001Assignees: The Regents of the University of California, Yale UniversityInventors: Gerald M. Rubin, Duojia Pan, Jenny Rooke, Reza Yavari, Tian Xu
-
Patent number: 5935792Abstract: Members of a novel family of polypeptides, the KUZ family, are metalloproteases involved in neuronal partitioning and neuronal development.Type: GrantFiled: August 27, 1997Date of Patent: August 10, 1999Assignees: The Regents of the University of California, Yale UniversityInventors: Gerald M. Rubin, Duojia Pan, Jenny Rooke, Reza Yavari, Tian Xu